Sales decline 2.25% to Rs 3621.07 crore
Net profit of Aurobindo Pharma declined 11.36% to Rs 518.51 crore in the quarter ended June 2017 as against Rs 584.96 crore during the previous quarter ended June 2016. Sales declined 2.25% to Rs 3621.07 crore in the quarter ended June 2017 as against Rs 3704.60 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales3621.073704.60 -2 OPM %22.7224.00 -PBDT840.50891.98 -6 PBT709.32785.74 -10 NP518.51584.96 -11Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
